InterCure

InterCure EBIT per Share

The EBIT per Share of InterCure (INCR.TA) as of Oct 9, 2026 is -1.07 ILS. In the previous year, EBIT per Share was 0.70 ILS — a change of -254.50% (lower).

EBIT per Share

-1.07ILS

YoY

-254.50%

Last updated:

EBIT per Share of InterCure is 2024 -1.07 ILS. EBIT per Share of InterCure was 2023 0.70 ILS. It decreases by -254.50% lower compared to the previous year.

The InterCure EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2019
-0.13 ILS
Jan 1, 2020
-1.53 ILS
Jan 1, 2021
0.84 ILS
Jan 1, 2022
1.40 ILS
Jan 1, 2023
0.70 ILS
Jan 1, 2024
-1.07 ILS
Jan 1, 2025 (e)
1.15 ILS
Jan 1, 2026 (e)
2.04 ILS
The InterCure EBIT per Share history
YEAREBIT per ShareYoY
est2.04ILS+77.64%
est1.15ILS-206.79%
-1.07ILS-254.50%
0.70ILS-50.25%
1.40ILS+66.08%
0.84ILS-155.05%
-1.53ILS+1,055.33%
-0.13ILS-77.61%
-0.59ILS+137.28%
-0.25ILS-381.50%
0.09ILS-125.54%
-0.35ILS-58.53%
-0.84ILS—
Access this data via the Eulerpool API

InterCure Stock analysis

What does InterCure do? InterCure Ltd. is a global company in the medical technology industry that focuses on the development, production, and distribution of innovative solutions for the diagnosis and treatment of chronic diseases. The company was founded in Israel in 2000 and is headquartered in Lod. InterCure is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InterCure stock

EBIT per Share of InterCure is -1.07 ILS in 2024.

EBIT per Share of InterCure changed from 0.70 ILS to -1.07 ILS, representing a -254.50% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share InterCure since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

Income Statement — InterCure

All Key Metrics — InterCure